# US 2012/0232436 A1 · Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232436 A1
- Document ID: US20120232436A1
- Status: Published application
- Kind: A1
- Application number: 13/503,109
- Filed: 2010-10-29
- Published: 2012-09-13
- Earliest claimed: 2009-10-30
- Assignees: Sound Interventions, Inc.
- Inventors: Reinhard J. Warnking
- Web page: https://patentgrep.com/patent/US20120232436A1

## CPC

- A61M 25/0082: {Catheter tip comprising a tool}
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61N 7/022: {intracavitary}
- A61B 2017/003: {Steerable}
- A61B 2017/00323: {Cables or rods}
- A61B 2017/22021: {electric leads passing through the catheter}
- A61B 2018/00023: {closed, i.e. without wound contact by the fluid}
- A61M 25/0068: {Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure}
- A61M 2025/1047: {having centering means, e.g. balloons having an appropriate shape}
- A61M 2025/1068: {having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure}
- A61M 2025/1086: {having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves}
- A61M 2025/1093: {having particular tip characteristics}
- A61N 2007/0026: {Stimulation of nerve tissue}
- A61N 2007/0043: {intra-cavitary}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.

## Claims

### Claim 1

Apparatus for inactivating renal nerve conduction in a mammalian subject comprising:
an ultrasound transducer adapted for insertion into a renal artery of the mammalian subject and for transmitting unfocused ultrasound energy; and
an actuator electrically connected to the transducer, the actuator being adapted to control the ultrasound transducer to transmit unfocused ultrasound energy into an impact volume of at least 0.5 cm3, encompassing the renal artery so that the unfocused ultrasound energy is applied at a therapeutic level sufficient to inactivate conduction of renal nerves throughout the impact volume.

### Claim 2 (depends on 1)

The apparatus of claim 1, wherein the actuator is adapted to control the ultrasound transducer so that the unfocused ultrasound is applied throughout the impact volume at a level insufficient to cause rapid necrosis of tissues.

### Claim 3 (depends on 2)

The apparatus of claim 2, wherein the impact volume encompasses all of the renal nerves surrounding the renal artery.

### Claim 4 (depends on 1)

The apparatus of claim 1, wherein the actuator is adapted to control the ultrasound transducer to transmit unfocused ultrasound energy at an acoustic power level of 10 to 30 watts for 10 to 30 seconds to provide an absorbed dose of 100 to 900 joules in the impact volume.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein the actuator is adapted to control the transducer so as to maintain the temperature of the renal artery wall below 65° C. while achieving a temperature above 42° C. throughout the impact volume for several seconds or more.

### Claim 6 (depends on 1)

The apparatus of claim 1, wherein the actuator is adapted to control the ultrasound transducer to transmit the unfocused ultrasound energy in a pulsed function.

### Claim 7 (depends on 1)

The apparatus of claim 1, wherein the ultrasound transducer is adapted to transmit the ultrasound energy in a pattern having a length of at least approximately 2 mm along the axis of the renal artery.

### Claim 8 (depends on 1)

The apparatus of claim 1, wherein the transducer is adapted to apply the ultrasonic energy at the therapeutic level throughout an impact volume having a length of at least approximately 2 mm along the axis of the of the renal artery.

### Claim 9 (depends on 5)

The apparatus of claim 5, further comprising a catheter with a distal end and a proximal end, the transducer being mounted to the catheter adjacent the distal end, the catheter and transducer being constructed and arranged to allow a substantial flow of blood through the renal artery while the ultrasound transducer is positioned within the renal artery.

### Claim 10 (depends on 9)

The apparatus of claim 9, wherein the catheter is constructed and arranged to hold the transducer out of contact with the wall of the renal artery.

### Claim 11 (depends on 9)

The apparatus of claim 9, wherein the transducer has an axis, the catheter is constructed and arranged to hold the axis of the transducer generally parallel to the axis of the renal artery, and the transducer is adapted to transmit the ultrasound energy in a 360° cylindrical pattern surrounding the axis of the transducer.

### Claim 12 (depends on 10)

The apparatus of claim 10, wherein the catheter includes a centering element in proximity to the transducer, the centering element being arranged to hold the transducer substantially centered in the renal artery.

### Claim 13 (depends on 12)

The apparatus of claim 12, wherein the centering element includes an expansible element adapted to engage the wall of the renal artery without substantially blocking flow of blood through the renal artery.

### Claim 14 (depends on 1)

The apparatus of claim 1, wherein the ultrasound transducer is further adapted to receive ultrasound energy and generate signals representing the received ultrasonic energy and the actuator is further adapted to:
control the ultrasound transducer to transmit measurement ultrasound energy at a level below the therapeutic level, receive echo signals from the transducer representing reflected measurement ultrasonic energy;
analyze the received echo signals; and
determine a size of the renal artery based on the received echo signal.

### Claim 15 (depends on 14)

The apparatus of claim 14, wherein the ultrasound system is adapted to control the ultrasound transducer to vary the acoustic power used to transmit the therapeutically effective unfocused ultrasound energy depending on the determined size of the renal artery.

### Claim 16

A method for inactivating renal nerve conduction in a mammalian subject comprising the steps of:
inserting an ultrasound transducer into a renal artery of the mammalian subject; and
actuating the transducer to transmit a predetermined therapeutically effective dose of unfocused ultrasound energy into an impact volume of at least approximately 0.5 cm3, encompassing the renal artery so that the therapeutically effective dose of unfocused ultrasound energy inactivates conduction of all the renal nerves in the impact volume.

### Claim 17 (depends on 16)

The method of claim 16, wherein the ultrasound energy is transmitted at an acoustic power level of approximately 10 to approximately 30 watts for approximately 10 to approximately 30 seconds to provide an absorbed dose of approximately 100 to approximately 900 joules throughout the impact volume.

### Claim 18 (depends on 16)

The method of claim 16, wherein the step of transmitting ultrasound energy is performed so as to maintain the temperature of the renal artery wall below 65° C. while heating the renal nerves in the impact region to above 42° C.

### Claim 19 (depends on 16)

The method of claim 16, wherein the steps of inserting the ultrasound transducer and actuating the transducer to transmit ultrasound energy are performed without determining the actual locations of renal nerves.

### Claim 20 (depends on 16)

The method of claim 16, wherein the step of actuating the transducer is performed so that a single application of the ultrasound energy in each renal artery is effective to inactivate conduction of all the renal nerves surrounding that renal artery.

### Claim 21 (depends on 16)

The method of claim 16, further comprising the steps of:
repositioning the ultrasound transducer in the renal artery after the step of actuating the transducer; and then
repeating the step of actuating the transducer.

### Claim 22 (depends on 16)

The method of claim 16, wherein the step of actuating the transducer is performed so that the ultrasound energy is transmitted in a pulsed function.

### Claim 23 (depends on 16)

The method of claim 16, wherein the step of inserting the ultrasound transducer is performed so as to permit a substantial flow of blood through the renal artery while the transducer is positioned within the renal artery.

### Claim 24 (depends on 16)

The method of claim 16, wherein the step of inserting the ultrasound transducer into the renal artery is performed so that the transducer does not contact the wall of the renal artery.

### Claim 25 (depends on 16)

The method of claim 16, wherein the therapeutically effective unfocused ultrasound energy is transmitted in a 360° cylindrical pattern surrounding the transducer.

### Claim 26 (depends on 16)

The method of claim 16, wherein the therapeutically effective unfocused ultrasound energy is transmitted in a pattern having a length of at least approximately 2 mm along the axis of the renal artery.

### Claim 27 (depends on 16)

The method of claim 16, wherein the therapeutically effective unfocused ultrasound energy inactivates conduction of a length of at least approximately 2 mm of the renal nerves.

### Claim 28 (depends on 16)

The method of claim 16, further comprising the step of substantially centering the ultrasound transducer in the renal artery prior to the step of transmitting the therapeutically effective unfocused ultrasound energy.

### Claim 29 (depends on 27)

The method of claim 27, wherein the step of substantially centering the transducer is performed so as to allow a substantially undiminished flow of blood through the renal artery.

### Claim 30 (depends on 16)

The method of claim 16, further comprising the steps of:
applying non-therapeutic ultrasound energy at a power level less than a power level of the therapeutically effective ultrasonic energy;
receiving reflected non-therapeutic ultrasonic energy and generating echo signals representing the reflected energy; and
determining a size of the renal artery based on the echo signals before the step of actuating the transducer to apply the therapeutically effective ultrasonic energy.

### Claim 31 (depends on 30)

The method of claim 30, further comprising the step of adjusting the power applied to the transducer during actuation to emit therapeutically effective unfocused ultrasound energy based at least in part on the size of the renal artery determined in the determining step.

### Claim 32

A probe for use in renal nerve inactivation, the probe comprising:
an ultrasound transducer adapted for transmitting unfocused ultrasound energy; and
a catheter with a distal end and a proximal end, the transducer being mounted to the catheter adjacent the distal end, the catheter and transducer being constructed and arranged to allow positioning of the distal end and transducer within a renal artery and to allow a substantial flow of blood through the renal artery while the ultrasound transducer is positioned within the renal artery.

### Claim 33 (depends on 32)

The probe of claim 32, wherein the catheter is constructed and arranged to hold the transducer out of contact with the wall of the renal artery.

### Claim 34 (depends on 32)

The probe of claim 32, wherein the transducer has an axis, the catheter is constructed and arranged to hold the axis of the transducer generally parallel to the axis of the renal artery, and the transducer is adapted to transmit the ultrasound energy in a 360° cylindrical pattern surrounding the axis of the transducer.

### Claim 35 (depends on 32)

The probe of claim 32, wherein the catheter includes a centering element in proximity to the transducer, the centering element being arranged to hold the transducer substantially centered in the renal artery.

### Claim 36 (depends on 35)

The probe of claim 35, wherein the centering element includes an expansible element adapted to engage the wall of the renal artery without substantially blocking flow of blood through the renal artery.

### Claim 37 (depends on 32)

The probe of claim 32 further comprising an inflatable balloon surrounding the transducer, the balloon having a non-circular portion which, in an inflated condition, has a major diameter adapted to contact the wall of the renal artery and has a minor diameter smaller than the diameter of the renal artery, the catheter having fluid lumens communicating with the balloon, the probe further comprising a circulation device communicating with the balloon through the lumens for circulating a liquid through the balloon.

### Claim 38

Apparatus for inactivating renal nerve conduction in a mammalian subject comprising:
an ultrasound transducer;
means for positioning the ultrasound transducer in a renal artery of the mammalian subject so that said transducer is spaced all around from a wall of said artery; and
means for actuating the transducer to transmit a predetermined therapeutically effective dose of unfocused ultrasound energy into an impact volume of at least 0.5 cm3, encompassing the renal artery and achieves a temperature above 42° C. throughout the impact volume for several seconds or more while maintaining the temperature of the renal artery wall below 65° C. so that the therapeutically effective dose of unfocused ultrasound energy inactivates conduction of all the renal nerves which are disposed in the impact volume without damaging the intima of the renal artery.

### Claim 39

An apparatus for inactivating renal nerves comprising:
an ultrasound transducer adapted to emit unfocused ultrasound energy radially outwardly at a frequency transmittable through the renal artery to the renal nerves, the ultrasound transducer having:
a shape suitable to produce unfocused ultrasound energy with a length of at least 2 mm,
an axial length suitable for insertion into the renal artery, and
a diameter suitable to allow fluid to flow around the transducer while the transducer is inserted in the renal artery, the fluid providing cooling to the renal artery;
and
an actuator electrically connected to the transducer, the actuator adapted to control the ultrasound transducer to transmit the unfocused ultrasound energy at a power level and duration that generates:
a near field region of ultrasound energy that encompasses the renal artery, and
a therapeutic ultrasound energy level in the near field region that is sufficient to inactivate the renal nerves.

### Claim 40 (depends on 39)

The apparatus of claim 39, wherein the actuator is adapted to control the ultrasound transducer to transmit unfocused ultrasound energy at a frequency of 5 MHz to 15 MHz.

### Claim 41 (depends on 39)

The apparatus of claim 39, wherein the shape of the transducer is cylindrical and transmits the unfocused ultrasound energy in a 360° cylindrical pattern.

### Claim 42 (depends on 39)

The apparatus of claim 39, wherein the near field region does not encompass other structures of the body.

### Claim 43 (depends on 39)

The apparatus of claim 39, wherein the fluid providing cooling to the renal artery is a continuous flow of blood through the renal artery.

### Claim 44 (depends on 39)

The apparatus of claim 39, further comprising:
a catheter with a distal end and a proximal end, the ultrasound transducer mounted to the catheter adjacent the distal end;
an expansible element mounted to the catheter in proximity to the ultrasound transducer.

### Claim 45 (depends on 44)

The apparatus of claim 44, wherein the expansible element contains cooling fluid to cool the transducer and the renal artery.

### Claim 46 (depends on 44)

The apparatus of claim 44, wherein the expansible element is shaped to allow a continuous flow of blood to cool the renal artery.

### Claim 47 (depends on 44)

The apparatus of claim 44, wherein the expansible element is a centering element.

### Claim 48 (depends on 39)

The apparatus of claim 39, wherein the power level is an acoustic power level of 10 to 30 watts and the duration is 10 to 30 seconds to provide an absorbed dose of 100 to 900 joules in the near field region.

### Claim 49 (depends on 39)

The apparatus of claim 39, wherein the therapeutic ultrasound energy level maintains the temperature of the renal artery wall below 65° C. while achieving a temperature above 42° C. throughout the near field region for several seconds or more.

### Claim 50 (depends on 39)

The apparatus of claim 39, wherein the unfocused ultrasound is applied throughout the near field region at a level insufficient to cause rapid necrosis of tissues.

### Claim 51 (depends on 39)

The apparatus of claim 39, wherein the near field region encompasses all of the renal nerves surrounding the renal artery.

### Claim 52

An apparatus for deactivating renal nerves to treat hypertension, comprising:
an ultrasound transducer device configured to generate a volumetric distribution of ultrasound radiation where intensity of an ultrasound field decreases with distance from the transducer device, said transducer device being so dimensioned as to enable insertion and disposition thereof inside a renal artery;
a support element operatively connected to said transducer device, said support element being configured to support said transducer device so that said transducer device is not in contact with renal artery tissue; and
a control unit operatively connected to said transducer device for energizing same with an ultrasonic electrical signal with frequency, amplitude, and duration parameters selected so that said volumetric distribution of ultrasound radiation encompasses the renal artery and has a therapeutic ultrasound energy level that is sufficient to inactivate renal nerves within said volumetric distribution of ultrasound radiation.

### Claim 53 (depends on 52)

The apparatus of claim 52 wherein said ultrasound transducer device has a length of about 2 mm and said volumetric distribution of ultrasound radiation has a length of about 2 mm.

### Claim 54 (depends on 52)

The apparatus of claim 52 wherein said ultrasound transducer device is configured to generate a cylindrical distribution of ultrasound radiation.

### Claim 55 (depends on 52)

The apparatus of claim 52 wherein said support element is a centering element allowing for blood flow through the renal artery and past said transducer.

### Claim 56 (depends on 52)

The apparatus of claim 52 wherein said volumetric distribution of ultrasound radiation encompasses all renal nerves within a predetermined distance of said transducer device.

### Claim 57

A method for deactivating renal nerves to treat hypertension, comprising:
inserting an ultrasound transducer into a renal artery;
feeding an electrical signal of ultrasonic frequency to said transducer; and
in response to the feeding of said electrical signal, energizing said transducer to generate a volumetric ultrasound field that decreases in intensity with distance from said transducer and that encompasses a long segment of said renal artery, including renal nerves dispersed circumferentially and longitudinally along said renal artery,
wherein said electrical signal has frequency, amplitude, and duration parameters selected to produce a therapeutic ultrasound energy level within said volumetric ultrasound field sufficient to inactivate renal nerves throughout said volumetric ultrasound field.

### Claim 58 (depends on 57)

The method of claim 57 wherein said volumetric ultrasound field is axially symmetric about said transducer.

### Claim 59 (depends on 58)

The method of claim 58, further comprising positioning said transducer within the renal artery so that said transducer is not in contact with arterial tissue.
